Trial intelligence / Profile preview

Nasal Carbon Dioxide for Mild Migraine Headache

NCT00690716Phase 2Completed

Sponsor
Capnia, Inc.
Start
Aug 2008
Primary completion
Jun 2009
Modality
Inhalation Devices
Countries
1
01

Overview

A Phase 2 trial of Carbon dioxide in migraine, sponsored by Capnia, Inc.. Started Aug 2008; status: completed.

02

Drugs

Carbon dioxide
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00690716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00690716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call